Status:
UNKNOWN
Meta-analysis of Low GI/GL Diets and Cardiometabolic Risk in Diabetes
Lead Sponsor:
University of Toronto
Conditions:
Diabetes
Eligibility:
All Genders
Brief Summary
Low glycemic index and low glycemic load diets have been shown to improve glycemic control and cardiometabolic risk factors in randomized controlled trials in people with diabetes and are associated w...
Detailed Description
Background: The prevalence of diabetes continues to rise globally and remains a major cause of cardiovascular disease and a leading cause of death. Diet and lifestyle remain the cornerstone of therapy...
Eligibility Criteria
Inclusion
- Dietary trials in humans
- Randomized treatment allocation
- ≥3 weeks
- Suitable control (i.e. isocaloric diet that is not low GI or low GL)
- Viable endpoint data
Exclusion
- Non-human studies
- Non-randomized treatment allocation
- \<3 weeks
- Lack of a suitable control (i.e. non-isocaloric)
- No viable endpoint data
Key Trial Info
Start Date :
August 1 2019
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
June 30 2021
Estimated Enrollment :
1 Patients enrolled
Trial Details
Trial ID
NCT04045938
Start Date
August 1 2019
End Date
June 30 2021
Last Update
May 17 2021
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
University of Toronto
Toronto, Ontario, Canada, M5C2T2